Baseline | Follow up | |||||
---|---|---|---|---|---|---|
Silent ischaemia (n = 643) | Symptomatic ischaemia (n = 288) | p Value | Silent ischaemia (n = 643) | Symptomatic ischaemia (n = 288) | p Value | |
β blockers | 243 (38%) | 115 (40%) | 0.5 | 276 (43%) | 202 (70%) | <0.001 |
Calcium channel blockers | 177 (27%) | 99 (34%) | 0.04 | 193 (30%) | 89 (31%) | 0.06 |
Nitrates | 180 (28%) | 115 (40%) | 0.001 | 193 (30%) | 69 (24%) | <0.006 |
Aspirin | 302 (47%) | 158 (55%) | 0.005 | 334 (52%) | 236 (82%) | <0.001 |
Statins | 174 (27%) | 92 (32%) | 0.1 | 263 (41%) | 245 (85%) | <0.001 |